N-Hydroxyphthalimide
N-Hydroxyphthalimide is a blocking agent and catalyst. N-Hydroxyphthalimide promotes oxidation reactions by generating PINO free radicals and activating hydrogen atom transfer processes. N-Hydroxyphthalimide reduces the expression of anti-apoptotic proteins Survivin and Bcl-xL and activates caspase 9 and caspase 3. N-Hydroxyphthalimide induces Apoptosis. N-Hydroxyphthalimide inhibits the phosphorylation of mTOR (Ser2448, Ser2481) and Akt (Ser473) . N-Hydroxyphthalimide has anticancer effects against breast and colon cancer[1][2][3].
Product Specifications
CAS Number
[524-38-9]
UNSPSC
12352200
Hazard Statement
H302, H315, H319, H335
Target
Akt; Apoptosis; Bcl-2 Family; Biochemical Assay Reagents; Caspase; mTOR; Survivin
Type
Biochemical Assay Reagents
Related Pathways
Apoptosis; Others; PI3K/Akt/mTOR
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/n-hydroxyphthalimide.html
Purity
99.89
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1C2=C(C(N1O)=O)C=CC=C2
Molecular Formula
C8H5NO3
Molecular Weight
163.13
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Isoform
Bcl-xL; Caspase 3; Caspase 9
Available Sizes
Explore Other Products
Browse additional items from our catalog
RPA1, CT (RPA1, REPA1, RPA70, Replication protein A 70kD DNA-binding subunit, Replication factor A protein 1, Single-stranded DNA-binding protein) (AP) discontinued
PRAMEF12 CRISPR Knock Out 293T Cell Line (Human)
Lcmt1 sgRNA CRISPR Lentivector (Mouse) (Target 2)
